Cassava Sciences EPS Basic from Extraordinaries (Quarterly) Analysis

Cassava Sciences, Inc. (SAVA)

2.08 -0.02 (-0.95%) USD | NASDAQ | Jan 12, 12:00

View EPS Basic from Extraordinaries (Quarterly) for SAVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

cbdMD, Inc.	--
BioMarin Pharmaceutical, Inc.	--
Amicus Therapeutics, Inc.	--
Geron Corp.	--
NovaBay Pharmaceuticals, Inc.	--